Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Healthy Returns

Recent news which mentions Healthy Returns

< Previous 1 2 Next >
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Social issues Centene Corp Healthy Returns
From CNBC.com News
Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs
Tags Health care industry Biotech and Pharmaceuticals Healthy Returns
From CNBC.com News
Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly’
Tags Social issues Health & Science Healthy Returns
From CNBC.com News
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Tags Health care industry Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags LILLY DRN Science Health & Science
From CNBC.com News
Healthy Returns: What to know about the U.S. measles outbreak
Tags Science Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Science Health & Science Social issues
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Structure Therapeutics Inc Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: HHS Secretary RFK Jr. is making early moves that may affect vaccine access
Tags Healthy Returns Oracle Corp Health & Science
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags LILLY DRN Science Health & Science
From CNBC.com News
Healthy Returns: What to know about Trump's NIH funding cuts
Tags Biotech and Pharmaceuticals Health care industry Social issues
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags LILLY DRN Science Health & Science
From CNBC.com News
Healthy Returns: Trump made sweeping changes to health care in his first week
Tags Government and politics Health & Science Social issues
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Social issues Health & Science Johnson & Johnson
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Merck & Co Inc Iovance Biotherapeutics Inc Amgen Inc
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Biotech and Pharmaceuticals LILLY DRN Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Healthy Returns Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Health & Science Social issues LILLY DRN
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Healthy Returns Health care industry AstraZeneca PLC
From CNBC.com News
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
Tags Healthy Returns Health & Science Social issues
From CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Healthy Returns Dexcom Inc Health care industry
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Tags Healthy Returns Health & Science Social issues
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Health care industry AstraZeneca PLC Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Science Health & Science Social issues
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Health care industry Microsoft Corp Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Health & Science Social issues LILLY DRN
From CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
Tags Social issues Hims & Hers Health Inc Health & Science
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Tags Healthy Returns Health care industry Pfizer Inc
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Social issues Health & Science Healthy Returns
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Social issues Health & Science Eli Lilly and Co
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.